{"id":528358,"date":"2021-02-01T16:44:01","date_gmt":"2021-02-01T16:44:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=528358"},"modified":"2021-02-01T16:44:01","modified_gmt":"2021-02-01T16:44:01","slug":"clostridium-difficile-infections-market-report-insights","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/clostridium-difficile-infections-market-report-insights_528358.html","title":{"rendered":"Clostridium Difficile Infections Market Report Insights"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Clostridium Difficile Infections Market Report Insights \" src=\"https:\/\/www.abnewswire.com\/uploads\/1585648587.jpeg\" alt=\"Clostridium Difficile Infections Market Report Insights \" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP      <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Clostridium Difficile Infections Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Clostridium Difficile Infections, historical and forecasted epidemiology as well as the Clostridium Difficile Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>What is Clostridium Difficile Infections?&nbsp; <\/strong><\/p>\n<p style=\"text-align: justify;\">Clostridium Difficile Infection (CDI) is a gastrointestinal infection caused by bacterium Clostridium difficile. It commonly affects those individuals who have been exposed to antibiotics therapy, extended hospitalization, and long-term medical care.<\/p>\n<p style=\"text-align: justify;\"><strong>How many people are affected by<\/strong> <strong>Clostridium Difficile Infections?<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>In the US, Clostridium Difficile Infection incidence was 48.53 and 77.49 cases per 100,000 in males and females, respectively in outpatient settings.<\/li>\n<li>The incidence of Clostridium Difficile Infection at inpatient settings was 63 and 70.77 cases per 100,000 in males and females, respectively.<\/li>\n<li>Among the Clostridium Difficile Infection patients, female show a higher proportion of incidence as compared to males.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Request for free sample pages @ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/clostridium-difficile-infections-clostridium-difficile-associated-disease-market\"><strong>Clostridium Difficile Infections Market Forecast<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>How will Clostridium Difficile Infections Market change in upcoming years?&nbsp; <\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/clostridium-difficile-infections-clostridium-difficile-associated-disease-market\"><strong>Clostridium Difficile Infection market dynamics<\/strong><\/a> is anticipated to change in the coming years owing to the rise in the use of antimicrobial agents, which will result in more Clostridium Difficile Infection incident cases.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/0d718691ddb997feb34dc7d42ee90cbd.png\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The emerging therapies that will boost the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/clostridium-difficile-infections-clostridium-difficile-associated-disease-market\"><strong>Clostridium Difficile Infection market<\/strong><\/a> in the coming years includes SER 109, Ridinilazole, RBX2660, CP101, and DAV132.<\/p>\n<p style=\"text-align: justify;\">Companies across the globe are working diligently toward the development of new Clostridium Difficile Infection treatment therapies. The key players are <strong>Seres Therapeutics, Summit Therapeutics, Rebiotix Inc., Finch Therapeutics and Da Volterra.<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for free sample pages @ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/clostridium-difficile-infections-clostridium-difficile-associated-disease-market\"><strong>Clostridium Difficile Infections Market Trends <\/strong><\/a><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56407.html\" rel=\"nofollow\">DelveInsight<\/a><br \/><strong>Contact Person:<\/strong> Priya Maurya<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=clostridium-difficile-infections-market-report-insights\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=clostridium-difficile-infections-market-report-insights\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight&#8217;s &#8220;Clostridium Difficile Infections Market Insights, Epidemiology, and Market Forecast-2030&#8221; report delivers an in-depth understanding of the Clostridium Difficile Infections, historical and forecasted epidemiology as well as the Clostridium Difficile Infections market trends in the United &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/clostridium-difficile-infections-market-report-insights_528358.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,423,420,403,404],"tags":[],"class_list":["post-528358","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/528358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=528358"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/528358\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=528358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=528358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=528358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}